Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis

Neurotherapeutics(2022)10.1007/s13311-022-01262-3Source: DataRank Database

Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis is a research paper published in Neurotherapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.29)OA: bronzeTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Davide Trotti ORCID,Andrew T. Nelson ORCID

Live enrichment

PubMed:35773551 PMC:PMC9587161 OpenAlex:https://openalex.org/W4283720179

National Institute on Aging

Grant: RF1-AG057882

Muscular Dystrophy Association

Grant: 628389

National Institutes of Health

Grant: F31-NS118838

NINDS NIH HHS

Grant: F31 NS118838

NIA NIH HHS

Grant: RF1 AG057882

National Institutes of Health

Grant: 1RF1AG057882-01

Exosome-mediated propagation of disease linked poly-dipeptides in C9orf72-FTD/ALS

National Institutes of Health

Grant: 5F31NS118838-02

Metabolic perturbations as a modifier of repeat-associated non-AUG translation in C9orf72-linked ALS/FTD

FWCI

3.29

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttps://link.springer.com/content/pdf/10.1007/s13311-022-01262-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s13311-022-01262-3.pdf

publisherhttps://link.springer.com/article/10.1007/s13311-022-01262-3/fulltext.html

publisherhttps://api.elsevier.com/content/article/PII:S187874792301070X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S187874792301070X?httpAccept=text/plain

Fields of Study

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchParkinson's Disease Mechanisms and Treatments0301 basic medicine03 medical and health sciences0302 clinical medicineHumansAmyotrophic Lateral SclerosisNeurodegenerative DiseasesEnergy MetabolismHomeostasisMotor Neurons

MeSH Terms

Amyotrophic Lateral SclerosisEnergy MetabolismHomeostasisHumansMotor NeuronsNeurodegenerative Diseases

Keywords

Amyotrophic lateral sclerosisHypermetabolismDiseaseNeuroscienceNeurologyBioenergeticsEnergy homeostasisMedicineProteostasisAtrophyNeurochemistryNeurodegenerationBiologyBioinformaticsMitochondrionPathologyInternal medicineLipidsMetabolismGlucoseATPALSglycolysisMotor NeuronsHumansHomeostasisNeurodegenerative DiseasesEnergy Metabolism

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being